Nosocomial bacteremia caused by Acinetobacter baumannii (AB) is of increasing concern in critically ill patients, and the risk factors for this infection are not well established. An inception cohort study in a 40-bed medical and surgical intensive care unit (ICU) at a single institution was conducted during a 2-year period to determine the risk factors for AB nosocomial bacteremia. Risk factors related to the underlying diseases, the clinical picture at admission, and those acquired during the stay in the ICU were recorded upon admission and daily throughout the ICU stay. We defined an "invasive procedures index" as the number of invasive procedures performed every day during the ICU stay before the onset of AB bacteremia divided by the number of days in the ICU before the onset of AB bacteremia. Risk factors that were independently associated with AB bacteremia were immunosuppression, unscheduled admission to the hospital, respiratory failure at ICU admission, previous antimicrobial therapy, previous sepsis in the ICU, and the invasive procedures index.
crease in mortality rates and length of stay in the ICU attributable to AB infection in a matched case-control study of critically ill patients [13] . The virulence of this pathogen is enhanced by the frequent development of multiple antimicrobial resistance, which severely restricts the therapeutic options [6, 12, 14, 15] .
Epidemic outbreaks of AB nosocomial infections have developed in different hospital areas, but mainly in the ICU [16] [17] [18] [19] [20] [21] [22] [23] . The role of AB acquisition in the ICU, however, is not often easy to elucidate. Because of its wide distribution and colonizing capability, AB does not always act as an infecting pathogen [19, 24, 25] . Moreover, it seems that the epidemiologic pattern of acquisition and dissemination of AB differs from that of other nonfermentative, gram-negative bacilli. In addition, risk factors may vary in areas with endemic colonization or epidemic outbreaks of infection [26] .
Although various factors predisposing to AB infections have been analyzed in different series, there has not been a prospective study carried out in a large cohort of critically ill patients to determine the risk factors for ICU-acquired AB nosocomial bacteremia. Therefore, we designed an inception cohort study, and our main aim was to establish the risk factors for AB nosocomial bloodstream infection in critically ill patients.
PATIENTS AND METHODS

Setting.
The Virgen del Rocío University Hospital is a tertiary hospital center with teaching accreditation that serves 750,000 people in its health care district. The medical-surgical ICU has 40 beds and annually attends to 11400 critically ill patients.
Study design. We conducted a prospective cohort study of critically ill patients who were admitted to the ICU during a 2-year period. Every patient was surveyed to detect bloodstream infections, and the risk factors for nosocomial infection were collected daily. No surveillance blood cultures were performed during the study period. Nosocomial ICU-acquired bacteremia was defined as the isolation of 1 or more viable specimens in blood cultures 48 h after a patient was admitted to the ICU. Only the first isolation was considered. The presence of a true case of bacteremia was evaluated by the physician in charge on the basis of the patient's history, clinical findings, microbiological results, and the number of positive blood cultures. The origin of the AB bacteremia was determined in each case of true bacteremia according to reported criteria [27] . Catheter-related bacteremia was diagnosed when the same strain was isolated in blood cultures and semiquantitative culture of a catheter segment (yielding у15 colonies) or if there was a clear clinical response after removal of the catheter. Polymicrobial bacteremia was defined as the isolation of 11 microorganism during a single bacteremic episode, excluding contaminations.
The following variables were analyzed: patient age, sex, and the presence of underlying diseases or conditions, including chronic obstructive pulmonary disease (COPD), diabetes mellitus, end-stage renal disease, history of alcohol abuse, solid neoplasm, neurological disorders, hematological malignancies, hepatic cirrhosis, and chronic cardiac failure, as defined elsewhere [28] . Immunosuppression was defined as presence or history of any of the following: splenectomy, corticosteroid therapy during the month prior to admission (prednisone, 20 mg q.d. [ [29] ; receipt of antimicrobial therapy for у48 h during the 2 weeks prior to admission to the ICU; and Acute Physiology and Chronic Health Evaluation (APACHE) II score [30] .
Risk factors acquired in the ICU included the following: number of days in the ICU before the onset of AB bacteremia, use of invasive procedures (placement or performance of arterial catheter, abdominal drainages, central venous catheter, mechanical ventilation, nasogastric tube, peripheral vein catheter, pulmonary artery catheter, thoracic drainage, or urinary catheter), and days spent undergoing an invasive procedure. We defined the "invasive procedures index" as the number of invasive procedures performed every day (see above) during the ICU stay before the onset of AB bacteremia divided by the number of days in the ICU before the onset of AB bacteremia. This index reflects, in 1 number, the mean number of invasive devices used in an individual patient every day in the ICU.
Clinical events developed during ICU stay included the following: cardiopulmonary arrest, respiratory failure, cardiogenic pulmonary edema, sepsis, severe sepsis or septic shock, and multiorgan dysfunction syndrome (MODS), as defined elsewhere [31] . When respiratory failure or shock was present at ICU admission, a 48-h interval during which clinical signs were not present was required to define a new onset of these events.
Microbiological methods. All blood cultures were processed by the hospital microbiology laboratory using the Bactec NR-860 system (Becton Dickinson). Isolates were identified as AB by their gram-negative morphology, based on standard biochemical reactions (by use of the API20 NE system; bioMérieux); their ability to grow at 44ЊC; and by use of the MicroScan system (NegCombo Type 61 plates; Baxter Healthcare). Antimicrobial susceptibility testing was determined by using the MicroScan system (Neg Breakpoint Combo Panel 2I), according to the criteria established by the National Committee for Clinical Laboratory Standards [32] .
Statistical analysis. We compared the differences in the risk factors among patients with AB bacteremia and the rest of patients, patients with AB bacteremia and patients with non-AB bacteremia, and patients with AB bacteremia and patients with non-AB bacteremia, after excluding coagulase-negative Staphylococcus (CoNS) bloodstream infections. The x 2 test or Fisher's exact test were used for categorical variables and relative risk, and their corresponding 95% CIs were calculated. For parametric continuous variables, mean values were compared using 2 samples' unpaired t test, after correction for equality of variance (Levene's test). For nonparametric continuous variables, the 
Acinetobacter baumannii 42
Aeromonas species 1
Bacteroides species 3
Candida species 11
Clostridium species 1
Corynebacterium species 2
Enterobacter aerogenes 3
Enterobacter cloacae 3
Enterococcus faecalis 17
Enterococcus faecium 6
Escherichia coli 9
Flavobacterium brevis 1
Haemophilus influenzae 1
Klebsiella pneumoniae 12
Morganella morgagnii 3 Nonenterococcal group D Streptococcus 1 Nonfermentative gram-negative rod 1
Peptostreptococcus species 1
Pseudomonas aeruginosa 14
Serratia marcescens 3 MR Staphylococcus aureus 4 MS S. aureus 35
Staphylococcus epidermidis 46
Staphylococcus species 22
Streptococcus b-haemolyticus 2
Streptococcus viridans 6
NOTE. There were 16 cases of polymicrobial bacteremia. MR, methicillin-resistant; MS, methicillin-sensitive.
Mann-Whitney U test was used. A multivariate stepwise logistic regression was performed using variables with significant differences or association in the univariate analysis. The ORs and their corresponding 95% CIs for each variable were also calculated. Statistical significance was considered when P values were !.05, and those of !.20 are not shown. For the analysis, the SPSS software package, version 9.0 (SPSS) was used for the analysis. Mean values are presented as . means ‫ע‬ SD
RESULTS
From January 1994 through December 1995, 2709 patients were admitted to the ICU. The mean patient age was 56.5 ‫ע‬ 15.3 years. The mean APACHE II score during first 24 h was . The median duration of ICU stay was 5 days (range, 12.4 ‫ע‬ 5.9 0-167 days). The crude ICU mortality rate during this period was 18%. Sixty-nine patients were discharged during the first 48 h, which left 2640 patients to be analyzed. The case-mix of ICU patients included in the study is shown in table 1.
Invasive procedures index. The mean invasive procedures index in the whole population was , with a median 2.55 ‫ע‬ 1.28 value of 2.5 and a range of 0-7. The index was higher in nonsurvivors than it was in survivors ( vs. 3.44 ‫ע‬ 1. 33 2.38 ‫ע‬ ;
). It was also higher in patients with bacteremia 1.20 P ! .001 than it was in the rest of the patients ( vs. 3.35 ‫ע‬ 1. 25 2.47 ‫ע‬ ; ) .
Description of cases of bacteremia. A total of 340 patients presented with у1 episode of bacteremia during the study period. Sixty-eight episodes took place during the first 48 h after ICU admission, and other 39 blood cultures were considered to be contaminations. Finally, 233 patients who had у1 episode of ICU-acquired bloodstream infection were analyzed (cumulative incidence, 8.83%). Microorganisms isolated during these episodes of bacteremia are shown in table 2. There were 35 cases of non-AB, gram-negative bacteremia during the study period, and 42 patients had AB bacteremia (cumulative incidence, 1.59%), for a rate of 1.9 episodes per 1000 patient-days.
Polymicrobial bacteremia was detected in 4 cases associated with AB bacteremia.
Median time spent in the ICU before the onset of AB bacteremia was 7 days (range, 2-59 days). The origin of the bacteremia could be determined for 37 patients (88%), as follows: respiratory infection, in 22 patients (59%); abdominal infection, in 10 (27%); central venous catheter infection, in 4 (11%); and mediastinitis, in 1 (3%). The clinical picture of bacteremia was sepsis, in 23 cases (55%); severe sepsis, in 9 cases (21%); and septic shock, in 10 cases (24%). MODS was developed in 14 cases (33%), and 22 patients (52%) died in ICU. The mortality rate was higher among patients with AB bacteremia who received inappropriate antimicrobial therapy than it was among those who received appropriate antimicrobial therapy (8 [62%] of 13 patients vs. 14 [48%] of 29 patients;
). The mortality rate in the ICU among patients who P p .43 Nasogastric tube 4.5 (2-9) 0 (0-2) -
Peripheral venous line 0 (0-1) 0 (0-1) -
1.20
Pulmonary artery catheter 0 (0-0) 0 (0-0) -
Thoracic drain 0 (0-0) 0 (0-1) - ence of diabetes mellitus ( ) decreased the incidence P p .028 of AB among patients with bacteremia. By means of a multivariate analysis, we could determine those variables that were independently related to AB isolation among patients with bacteremia; these were respiratory failure at ICU admission (OR, 3.78; 95% CI, 1.82-7.87; ), the presence of an infection P ! .001 at ICU admission (OR, 3.36; 95% CI, 1.57-7.21; ), P p .002 and the invasive procedures index (OR, 1.44; 95% CI, 1.06-1.97;
). P p .02 When we compared differences among patients who had bacteremia with AB isolation versus those without AB isolation, excluding the 62 cases of CoNS bloodstream infection, univariate analysis showed that absence of diabetes mellitus ( 
DISCUSSION
This is the first prospective study to determine the risk factors for AB nosocomial bacteremia in a large cohort of critically ill patients. Our results demonstrate that immunosuppression, unscheduled admission, respiratory failure at admission, previous antimicrobial therapy, previous sepsis in ICU, and invasive procedures were independently related to the development of AB bacteremia.
Risk factors for AB acquisition in ICU settings have been analyzed in previous reports, but the majority of these studies were performed with a case-control design. Male sex, APACHE II score [33] , length of stay in the ICU [33, 34] , mechanical ventilation [12, 35, 36] , prior infection, antimicrobial therapy [12, 15, 33, 34, 37] , and enteral hyperalimentation [33, 36] were associated with AB acquisition by multivariate analysis. In a cohort study of mechanically ventilated patients, Baraibar et al. [38] found that neurosurgery, adult respiratory distress syndrome, head trauma, and large-volume pulmonary aspiration were independent risk factors for AB nosocomial pneumonia.
Risk factors for AB bacteremia have been studied in casecontrol studies. In these studies, the following were found to be associated with AB bacteremia in certain groups of patients: female sex, total body surface of burn 150%, prior colonization with AB, and use of hydrotherapy, were associated with AB bacteremia in burn patients [39] ; mean birth weight and prior antibiotic therapy, in neonatal ICU patients [5] ; and hyperalimentation, mechanical ventilation, as well as the use and duration of transducers, in adult ICU patients, [11] .
In the present study, we analyzed potential risk factors in a nonselected and consecutive population of critically ill patients.
The prospective cohort study design implies a more-exact estimation of risks [40] . Regarding underlying disease, immunosuppression was an independent risk factor for AB bacteremia: it increased the risk of this infection by 3-fold. This feature enhances the important opportunistic character of this microorganism, which affects compromised hosts, like lowbirth-weight neonates [11] , burned patients [39] , or malignancy carriers [41] .
Unscheduled admission independently increased the risk of AB bacteremia in ICU patients by 13 times. It could be related to more-severe disease, a lower level of control measures to prevent infections in urgent admissions, or to a higher degree of organ dysfunction. In this way, Villers et al. [37] reported that surgery in the emergency operating department was an independent risk factor for AB infection in a case-control epidemic study.
Respiratory failure at ICU admission independently increased the risk of AB bacteremia during ICU stay by almost 3 times, and this independent risk was maintained when patients who had AB bacteremia were compared with patients who had non-AB bacteremia, even when cases of CoNS bacteremia were excluded. Patients with respiratory dysfunction on ICU admission are prone to a faster respiratory colonization, which increases the risk for nosocomial pneumonia. The respiratory focus is currently the main origin of secondary AB bacteremia in ICU patients [8, 9, 14, 15, 42] , and mechanical ventilation is a recognized risk factor for colonization and infection with AB [35, 36] .
The presence of infection and previous antimicrobial therapy have been found to be predisposing factors for AB acquisition [25, 33, 35, 43] . In the present study, previous antimicrobial therapy and the development of sepsis during ICU stay involved a higher risk for AB bacteremia. Moreover, the presence of an infection on ICU admission was an independent risk factor for detection of AB in critically ill patients with bacteremia. These findings could be explained by the use of broad-spectrum antibiotics, which leads to the selection of multidrug-resistant microorganisms, such as AB. This is another compelling argument to discourage the overzealous use of broad-spectrum antibiotics in critically ill patients whenever possible.
Multiple invasive procedures have been related to a higher incidence of AB acquisition. Although some reservoirs with epidemiological impact have been identified in epidemic outbreaks of infection [16] [17] [18] [19] [20] 21] , the endemic pattern of infection in our study and in other studies [12] suggests that invasive devices are not intrinsically related factors, but that they probably reflect the severity of the illness. Our study revealed, in the univariate analysis, that multiple invasive devices were risk factors for AB bacteremia in ICU patients. When the multivariate analysis was performed, the invasive procedures index performed better than did other variables related to invasive devices, so it was included in the final model. The importance of the risk derived from this index is reflected by the fact that every new device (present every day from ICU admission) involved an 82% higher risk of AB bacteremia.
AB infections showed an endemic pattern during the study period. No epidemic outbreaks of infection that were attributable to definite sources were detected. Although colonized or infected patients were strictly isolated, this endemic infection was not effectively controlled. These facts must be considered to interpret the results, and they may limit the generalizability of the results.
In conclusion, a higher risk of AB nosocomial bacteremia was observed in critically ill patients with immunosuppression, unscheduled admission, respiratory failure, and sepsis development. Hence, strict control measurements, adequate use of antimicrobial agents, and appropriate use of invasive procedures could be important preventive measures in decreasing the incidence of these infections.
